Investor Presentaiton
Clarity's Advisory Board
Clarity's advisory board comprises global thought leaders with extensive capabilities, expertise and
experience in developing radiopharmaceuticals
Prof Oliver Sartor Prof Richard Wahl
Prof Jason Lewis Prof Andreas Kjaer
Dr Andrei lagaru
Dr Neal Shore
Prof Paul Donnelly
Medical oncologist
and an
internationally
recognised expert
in prostate cancer.
He is the Laborde
Professor for Cancer
Research, Medical
Director of the
Tulane Cancer
Center, and
Assistant Dean for
Oncology at Tulane
University School of
Medicine in New
Orleans, Louisiana.
The Elizabeth
Mallinckrodt
Professor, Chairman
of the Department
of Radiology and
Director of the
Mallinckrodt
Institute of
Radiology at
Washington
University School of
Medicine in St Louis.
The Emily Tow
Jackson Chair in
Oncology and
serves as Vice Chair
for Research in the
Department of
Radiology at
Memorial Sloan
Kettering Cancer
Center (MSK), Chief
of MSK's
Radiochemistry &
Imaging Sciences
Service, and
Director of MSK's
Radiochemistry and
Molecular Imaging
Probe Core Facility.
A professor at the
University of
Copenhagen and a
chief physician at
the Department of
Clinical Physiology,
Nuclear Medicine &
PET at
Rigshospitalet, the
National University
Hospital of
Denmark.
Dr lagaru is an award-
winning Professor of
Radiology Nuclear
Medicine and the
Chief of the Division of
Nuclear Medicine and
Molecular Imaging at
Stanford University. His
research focus
includes PET/MRI and
PET/CT imaging for
early cancer detection
as well as peptide-
based diagnostic
imaging and therapy.
Dr Shore MD, FACS is
the Chief Medical
Officer of
Urology/Surgical
Oncology at
GenesisCare, US and
the Medical Director of
Carolina Urologic
Research Centre. He
has conducted more
than 400 clinical trials
with a particular focus
on GU oncology
indications and is an
internationally
recognised expert and
researcher in systemic
therapies for patients
with advanced
urologic cancers.
The Clarity Group
leader of the
Donnelly Research
Group, The
University of
Melbourne, based
in the state-of-art
laboratories of the
Bio21 Institute of
Molecular Science
and Biotechnology.
CLARITY
2014 MEIE
33View entire presentation